Guardian Pharmacy Services, Inc.
GRDN
$20.33
-$0.57-2.73%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 329.31M | 338.57M | 314.39M | 300.04M | 275.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 329.31M | 338.57M | 314.39M | 300.04M | 275.41M |
| Cost of Revenue | 264.96M | 271.47M | 253.52M | 238.75M | 220.31M |
| Gross Profit | 64.35M | 67.10M | 60.88M | 61.29M | 55.10M |
| SG&A Expenses | 51.05M | 45.91M | 165.49M | 44.28M | 44.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 316.01M | 317.37M | 419.01M | 283.03M | 264.98M |
| Operating Income | 13.30M | 21.20M | -104.61M | 17.01M | 10.43M |
| Income Before Tax | 13.11M | 16.22M | -105.64M | 15.85M | 4.31M |
| Income Tax Expenses | 3.83M | 4.38M | 176.00K | -- | -- |
| Earnings from Continuing Operations | 9.27M | 11.84M | -105.82M | 15.85M | 4.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 175.00K | 102.00K | -6.82M | -5.22M | -4.31M |
| Net Income | 9.45M | 11.94M | -112.64M | 10.62M | 0.00 |
| EBIT | 13.30M | 21.20M | -104.61M | 17.01M | 10.43M |
| EBITDA | 18.57M | 26.35M | -99.62M | 21.82M | 15.18M |
| EPS Basic | 0.15 | 0.19 | -2.00 | -- | -- |
| Normalized Basic EPS | 0.14 | 0.21 | -1.19 | -- | -- |
| EPS Diluted | 0.15 | 0.19 | -2.00 | -- | -- |
| Normalized Diluted EPS | 0.14 | 0.21 | -1.19 | -- | -- |
| Average Basic Shares Outstanding | 62.04M | 62.04M | 61.14M | -- | -- |
| Average Diluted Shares Outstanding | 62.91M | 62.72M | 61.14M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -10.93% | -- | -- |